https://pyfahealth.com/
Sat - Sun: Closed
Title Image

Shareholding Structure of the Company and Subsidiaries

Notes:

I. The shareholding structure of the Company and subsidiaries above is as per September 30st, 2021.

II. Rejuve Global Investment Pte. Ltd is controlled by Lee Ee Ling.

III. The Company’s Subsidiaries are as follow:

  1. PYFA HEALTH SINGAPORE PTE. LTD., which is engaged in research and experimental development on biotechnology, life, and medical science. The company has started its investment in PYFA HEALTH SINGAPORE PTE. LTD as of 2020.
  2. PT PYFA MEDIKA INDONESIA, which is engaged in retail trade of pharmaceutical goods in pharmacies; laboratory, pharmaceutical and health equipment; laboratory testing services; and activities to support health services. It was established on March 2021.
  3. PT MEGA INTER DISTRINDO, which is engaged in large trade in pharmaceutical; traditional medicine; cosmetics; as well as laboratory, pharmaceutical and medical equipment. It was established on March 2021.
  4. PT PYFA INVESTAMA MEDIKA, which is engaged in large trade with fees or based on contracts; holding company activities; accounting bookkeeping and auditing activities; other management consulting activities; business consulting and business brokerage activities; and the activities of joint office administration service providers. It was established on March 2021.
  5. PT PYFA SEHAT INDONESIA, which is engaged in (i) retail trade of pharmaceutical goods in pharmacies and non-pharmacies; traditional medicine; cosmetics; laboratory; pharmaceutical and health equipment; (ii) retail trade through the media; (iii) packaging activities; and (iv) web portals and/or digital platforms for commercial purposes. It was established on March 2021.